Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

'Fortunate To Get A Chance To Develop Navi Mumbai Airport': Gautam Adani Calls NMIA Launch A...

'Fortunate To Get A Chance To Develop Navi Mumbai Airport': Gautam Adani Calls NMIA Launch A...

NBCC Buys Land In Dubai For AED 15 Million To Develop Mixed-Use Project, Marks Overseas Realty Foray

NBCC Buys Land In Dubai For AED 15 Million To Develop Mixed-Use Project, Marks Overseas Realty Foray

JK Tyre Completes Merger Of Cavendish Industries, Strengthening Scale And Operational Synergies

JK Tyre Completes Merger Of Cavendish Industries, Strengthening Scale And Operational Synergies

Housing Sales Dip 16 Per Cent To 98,019 Units In Oct–Dec Across Top 9 Cities: PropEquity

Housing Sales Dip 16 Per Cent To 98,019 Units In Oct–Dec Across Top 9 Cities: PropEquity

Rupee Slides 16 Paise To 89.79 Against Dollar As Foreign Fund Outflows and Bullion Demand Offset RBI...

Rupee Slides 16 Paise To 89.79 Against Dollar As Foreign Fund Outflows and Bullion Demand Offset RBI...